Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 505.87M P/E - EPS this Y 20.50% Ern Qtrly Grth -
Income -270.78M Forward P/E -1.99 EPS next Y 40.30% 50D Avg Chg -14.00%
Sales 100.9M PEG - EPS past 5Y - 200D Avg Chg -28.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -56.00%
Recommedations 1.40 Quick Ratio 0.54 Shares Outstanding 381.50M 52W Low Chg 14.00%
Insider Own 0.80% ROA -34.89% Shares Float 319.46M Beta 1.27
Inst Own 64.86% ROE - Shares Shorted/Prior 43.85M/39.66M Price 1.45
Gross Margin 50.62% Profit Margin -268.15% Avg. Volume 5,074,324 Target Price 6.50
Oper. Margin -190.59% Earnings Date Mar 12 Volume 3,487,658 Change -0.68%
About Agenus Inc.

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an anti-CTLA-4 monospecific antibody that is in Phase 2 clinical trial; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a tumor microenvironment conditioning anti-CD73/TGFß TRAP bi-functional antibody that has completed Phase 1 clinical trial; AGEN1571, an ILT2 monospecific antibody that is in Phase 1 clinical trial; BMS-986442, a TIGIT bispecific antibodies; and AGEN1327, a human monoclonal antibody. In addition, it develops INCAGN1876, a GITR monospecific antibody; INCAGN2390, a TIM-3 monospecific antibody; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4; UGN-301, a zalifrelimab intravesical solution for the treatment of cancers of the urinary tract that is in a Phase 1 clinical trial; AGENT 797, an iNKT cells that is in Phase 1 clinical trial for solid tumors, multiple myeloma, and viral ARDS; and AGEN1884, a first-generation anti-CTLA-4 monospecific antibody. The company operates under Agenus, MiNK, Prophage, Retrocyte Display, and Stimulon trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., Incyte Corporation, Merck Sharpe & Dohme, and Gilead Sciences, Inc. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Agenus Inc. News
02/19/24 Favourable Signals For Agenus: Numerous Insiders Acquired Stock
02/15/24 Why Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today
02/15/24 Ginkgo Bioworks and SaponiQx Awarded MCDC Contract to Discover and Manufacture Next-Generation Vaccine Adjuvants Using Generative Molecular Design
02/01/24 7 Analyst-Backed Stocks With Promising 10-Bagger Potential
01/31/24 Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
03:57 PM 3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
01/22/24 Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population
01/16/24 Institutional investors may adopt severe steps after Agenus Inc.'s (NASDAQ:AGEN) latest 16% drop adds to a year losses
01/05/24 Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/04/24 Agenus to Participate in B. Riley Healthcare Conference
10:10 AM Merck (MRK) & Daiichi Sankyo's Lung Cancer ADC Gets Priority Tag
12/24/23 2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
12/21/23 GSK, Hansoh Ink Deal to Develop Lung Cancer ADC Candidate
12/20/23 Botensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024
12/13/23 Blueprint (BPMC) Gets EC Nod for Ayvakit Expanded Use, Stock Up
12/11/23 Agenus to Receive $25 Million Milestone Payment from Bristol Myers Squibb for TIGIT-CD96 Bispecific Program
12/07/23 Century (IPSC) Up 36% on FDA Nod to Begin Phase I Lupus Study
12/07/23 Dr. Reddy's (RDY), COYA Ink Deal to Develop COYA 302 for ALS
12/06/23 Agenus (NASDAQ:AGEN) adds US$36m to market cap in the past 7 days, though investors from three years ago are still down 75%
11/30/23 Acadia (ACAD) Begins Alzheimer's Disease Psychosis Study (Revised)
AGEN Chatroom

User Image MRKR2025 Posted - 1 hour ago

$AGEN as GD said : What a long strange trip it's been

User Image OracleofOntario Posted - 13 hours ago

What bio stocks are people excited about these days? I'm tracking $XFOR $AGEN $AQST $ETON and $AGRX

User Image steven1x Posted - 13 hours ago

$AGEN what’s next https://investor.agenusbio.com/news/news-details/2024/BotensilimabBalstilimab-Breakthrough-Data-Presented-at-ASCO-GI-Shows-Unprecedented-Tumor-Shrinkage-and-Robust-Biomarker-Response-in-Prevalent-Colorectal-Cancer-Population/default.aspx

User Image weichsel1 Posted - 14 hours ago

$AGEN analysts give a 6.50 target. Even if the shares outstanding double in the next 10 months to provide cash flow before FDA approval, the per share price (same market cap) is 3.25…

User Image BiotechTrader41 Posted - 18 hours ago

$AGEN Following this one for around April time frame to get in. Probably getting shorted after the split unfortunately, but lots of catalysts between April-August

User Image Bane00 Posted - 1 day ago

$AGEN what really gets me this was actually going break a dollar and Garo panicked because he knew he didn’t have any attention making a deal and if you email his some he will let you know real quick that the ATM is back in business ! RS then dilution all over again because this guy doesn’t care about anything but his ego, shareholder , patient don’t care , sorry his son because he going join in the milking too. Funny he hires he son who peddles wine and now he is shareholder relation , best part is he will let you know that dilution is coming , he title doesn’t say anything about having a good relationship with shareholder lol!

User Image BooksandTennis Posted - 2 days ago

$AGEN GLTA... Enjoy your weekend everyone... Monday Agenus will be solid above 70 cents...

User Image tfm007 Posted - 2 days ago

$AGEN very

User Image Zenlama Posted - 2 days ago

$AGEN low volume, but Market Cap Up $16million at 2:30pm

User Image benderok37 Posted - 2 days ago

$IFRX Market cap 80millions. In 2021, $AGEN paid $3.7 billions for $CCXI (Avacopan) How true is

User Image SHRTSQZ Posted - 2 days ago

$AGEN ..

User Image aaronmag13 Posted - 2 days ago

$AGEN Steve Cohen bought 28.2 million shares 2 days ago. Can anyone here give me a brief summary of what’s going on here and why they split 20:1? I know what they do for cancer but what else am I missing here?

User Image OracleofOntario Posted - 2 days ago

$AGEN Garo had a ton of shares - he didn't need to buy 500k more at 0.65 to get ridiculously rich when this gets approval. But he did....

User Image Icemanja Posted - 2 days ago

$AGEN Lets do this agian

User Image ace6th Posted - 2 days ago

$AGEN its waking up......could be ready for a nice move up

User Image Gmanthemagnificent Posted - 2 days ago

$AGEN garo said no swing trading today, garo will be the only swinger today!

User Image Bane00 Posted - 2 days ago

$AGEN “Our preference is to use non-equity means to bring in cash resources. We have never said that we will not issue equity through the ATM. “

User Image HamburgerTim Posted - 2 days ago

$AGEN .65/.68 seems low risk, need to dig more.

User Image Zenlama Posted - 2 days ago

$AGEN still

User Image BooksandTennis Posted - 2 days ago

$AGEN Can't wait for Monday... If it runs up today especially...Would it be so terrible if Agenus hit 75 cents or above today?

User Image OracleofOntario Posted - 2 days ago

$AGEN No insiders have sold shares in past 12 months, only a couple of buys, so that's good.

User Image TetonsBluebirds Posted - 2 days ago

$AGEN Looking at nasdaq then institutional holdings then insider trading.

User Image TetonsBluebirds Posted - 3 days ago

$AGEN I'm looking at nasdaq.com/institionalholdings/insideractivity There I find CEO Garo with about 12 million shares. Yes, only one trade for 500,000 shares was a direct purchase (2/15/2024 at $ 0.65 per share). Key for me is that just having at least 12 million shares of AGEN, with possible mid-2024 early approval, means that the veeerrrry dreaded post-reverse-split-tsunami-share-dilution MIGHT not happen. He has skin in the game that he might not wish to flay off. AGEN is truly a speculative play, not a safe play. Approval might not be forthcoming or a sudden safety issue happens etc. That said, I've thought myself into buying some more shares.

User Image jacobsright Posted - 3 days ago

$AGEN one week ago garo armens announcement of the reverse split stopped the stock momentum and killed the 1 $ calls that could have been printed... why? who is he working for?

User Image tsuleymenov Posted - 3 days ago

$AGEN Is it possible to do this once? I go out.

User Image Biotechguy21 Posted - 3 days ago

$AGEN my mind is very right and healthy. How about you dog? 👀👀😂😂😂

User Image Ilygod Posted - 3 days ago


User Image Ilygod Posted - 3 days ago

$AGEN Impressive for a penny stock.

User Image jacobsright Posted - 3 days ago

$AGEN good night stuck holders!

User Image Johnyd Posted - 3 days ago

$AGEN OT: hilarious LA Times article about latest Trump rally Jackie Calmes.you'll p yourself.

Analyst Ratings
HC Wainwright & Co. Buy Aug 8, 23
EF Hutton Buy Jul 3, 23
HC Wainwright & Co. Buy Jul 3, 23
Baird Outperform Jun 6, 23
HC Wainwright & Co. Buy Jun 5, 23
EF Hutton Buy Jun 5, 23
EF Hutton Buy May 26, 23
B. Riley Securities Buy Mar 29, 23
EF Hutton Buy Mar 28, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
O'Day Steven J Chief Medical Office.. Chief Medical Officer Jan 04 Sell 3.06 38,679 118,358 61,321 01/06/22